HALOZYME REPORTS SECOND QUARTER 2023 FINANCIAL AND OPERATING RESULTS
Go back to HALOZYME REPORTS SECOND QUARTER 2023 FINANCIAL AND OPERATING RESULTS| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 78.62 -1.75 (2.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $80.37 | 52 Week High | $18.39 | |||
| Open | $80.44 | 52 Week Low | $6.96 | |||
| Day High | $81.94 | P/E | N/A | |||
| Day Low | $78.33 | EPS | $-0.58 | |||
| Volume | 1,782,772 | |||||
